enow.com Web Search

  1. Ads

    related to: newest treatment for ovarian cancer

Search results

  1. Results from the WOW.Com Content Network
  2. Sutro Biopharma Announces Selected Dose for Luvelta and ...

    lite.aol.com/tech/story/0022/20241210/9316697.htm

    About Luveltamab Tazevibulin Luveltamab tazevibulin, abbreviated as “luvelta” and formerly known as STRO-002, is a FRα-targeting antibody-drug conjugate (ADC) designed to treat a broad range of patients with ovarian cancer, including those with lower FRα-expression who are not eligible for approved treatment options targeting FRα.

  3. Nuvectis Pharma CEO Says Increased Dose Intensity ... - AOL

    www.aol.com/finance/nuvectis-pharma-ceo-says...

    Nuvectis Pharma, Inc. (NASDAQ:NVCT) stock is trading lower after the company reported data from the Phase 1b study evaluating NXP800 in patients with platinum-resistant ARID1a-mutated ovarian cancer.

  4. Ovarian cancer - Wikipedia

    en.wikipedia.org/wiki/Ovarian_cancer

    Serous ovarian cancer is the most common type of epithelial ovarian cancer and it accounts for about two-thirds of cases of epithelial ovarian cancer. [28] Low-grade serous carcinoma is less aggressive than high-grade serous carcinomas, though it does not typically respond well to chemotherapy or hormonal treatments. [ 28 ]

  5. Jill Kolesar - Wikipedia

    en.wikipedia.org/wiki/Jill_Kolesar

    She also pioneered the use of engineered extracellular vesicles to treat ovarian and other cancers, an approach that has demonstrated significant potential to advance cancer therapy. Following the breakthrough, Kolesar founded VesiCure Technologies, a biotech company focused on developing novel cancer treatments.

  6. Mirvetuximab soravtansine - Wikipedia

    en.wikipedia.org/wiki/Mirvetuximab_soravtansine

    Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. [ 2 ] [ 5 ] Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate.

  7. How Patrick Dempsey is Upgrading Cancer Care (for Free) - AOL

    www.aol.com/lifestyle/patrick-dempsey-upgrading...

    Patrick Dempsey: My mother was diagnosed with ovarian cancer in the late ‘90s, and she had over 12 recurrences and then ultimately in 2014, passed away. So that was my first real profound impact ...

  1. Ads

    related to: newest treatment for ovarian cancer